Long-Term Effects of an Intensive Prevention Program After Acute Myocardial Infarction.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 09 2021
Historique:
received: 02 04 2021
revised: 23 05 2021
accepted: 26 05 2021
pubmed: 10 7 2021
medline: 18 9 2021
entrez: 9 7 2021
Statut: ppublish

Résumé

Effective long-term prevention after myocardial infarction (MI) is crucial to reduce recurrent events. In this study the effects of a 12-months intensive prevention program (IPP), based on repetitive contacts between non-physician "prevention assistants" and patients, were evaluated. Patients after MI were randomly assigned to the IPP versus usual care (UC). Effects of IPP on risk factor control, clinical events and costs were investigated after 24 months. In a substudy efficacy of short reinterventions after more than 24 months ("Prevention Boosts") was analyzed. IPP was associated with a significantly better risk factor control compared to UC after 24 months and a trend towards less serious clinical events (12.5% vs 20.9%, log-rank p = 0.06). Economic analyses revealed that already after 24 months cost savings due to event reduction outweighted the costs of the prevention program (costs per patient 1,070 € in IPP vs 1,170 € in UC). Short reinterventions ("Prevention Boosts") more than 24 months after MI further improved risk factor control, such as LDL cholesterol and blood pressure lowering. In conclusion, IPP was associated with numerous beneficial effects on risk factor control, clinical events and costs. The study thereby demonstrates the efficacy of preventive long-term concepts after MI, based on repetitive contacts between non-physician coworkers and patients.

Identifiants

pubmed: 34238446
pii: S0002-9149(21)00513-0
doi: 10.1016/j.amjcard.2021.05.034
pii:
doi:

Substances chimiques

Cholesterol, LDL 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-13

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Rico Osteresch (R)

Bremen Institute for Heart and Circulation Research at the Klinikum Links der Weser, Bremen, Germany.

Andreas Fach (A)

Bremen Institute for Heart and Circulation Research at the Klinikum Links der Weser, Bremen, Germany.

Fabian-Simon Frielitz (FS)

Institute for Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.

Sven Meyer (S)

Department of Cardiology, University Hospital Oldenburg, Oldenburg, Germany.

Johannes Schmucker (J)

Bremen Institute for Heart and Circulation Research at the Klinikum Links der Weser, Bremen, Germany.

Stephan Rühle (S)

Bremen Institute for Heart and Circulation Research at the Klinikum Links der Weser, Bremen, Germany.

Tina Retzlaff (T)

Bremen Institute for Heart and Circulation Research at the Klinikum Links der Weser, Bremen, Germany.

Moritz Hadwiger (M)

Institute for Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.

Tobias Härle (T)

Department of Cardiology, University Hospital Oldenburg, Oldenburg, Germany.

Albrecht Elsässer (A)

Department of Cardiology, University Hospital Oldenburg, Oldenburg, Germany.

Alexander Katalinic (A)

Institute for Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.

Ingo Eitel (I)

Medical Clinic II, Lübeck University Heart Center, Lübeck, Germany.

Rainer Hambrecht (R)

Bremen Institute for Heart and Circulation Research at the Klinikum Links der Weser, Bremen, Germany.

Harm Wienbergen (H)

Bremen Institute for Heart and Circulation Research at the Klinikum Links der Weser, Bremen, Germany; Medical Clinic II, Lübeck University Heart Center, Lübeck, Germany. Electronic address: harm.wienbergen@klinikum-bremen-ldw.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH